Key result
The CC genotype of the ADRB1 (1165G>C) polymorphism was associated with an increased risk of stroke compared to the GC + GG genotype in Chinese hypertensive patients (OR 1.184, P<0.05).
Why the study?
Antihypertensive therapy efficacy varies across individuals partially due to genetic variations, motivating investigation into how antihypertensive drug-related gene polymorphisms relate to stroke in hypertensive patients.
Observational
Odds Ratio: 1.184
p-value: p=<0.05
Should not change stroke prevention in hypertension; leaves open ADRB1 genotyping utility pending prospective validation.
Background . Antihypertensive therapy is crucial for preventing stroke in hypertensive patients. However, the efficacy of antihypertensive therapy varies across individuals, partially due to therapy‐related genetic variations among individuals. We investigated the association of antihypertensive drug‐related gene polymorphism with stroke in patients with hypertension. Methods . Demographic information, medication, and outcome data were obtained from a hypertensive patient management system, and a PCR fluorescence probe technique was used to detect 7 gene polymorphic loci ( CYP2D6 ∗ 10 , ADRB1 , CYP2C9 ∗ 3 , AGTR1 , ACE , CYP3A5 ∗ 3 , and NPPA ), and these loci were compared between patients with and without stroke. Logistic regression was performed to analyze the association of these genetic variations with stroke risk in hypertensive patients while controlling for potential factors. Results . The prevalence of stroke in the hypertensive population in Changsha County of Hunan Province was 2.75%. The mutation frequencies of ADRB1 ( 1165G > C ), CYP2D6 ∗ 10 , CYP2C9 ∗ 3 , AGTR1 ( 1166A > C ), ACE ( I / D ), NPPA ( 2238T > C ), and CYP3A5 ∗ 3 were 74.43%, 57.23%, 4.26%, 5.71%, 31.62%, 1.17%, and 69.58%, respectively. Univariate analysis revealed that ADRB1 polymorphism was associated with stroke ( χ 2 = 8.659, P < 0.05), with a higher stroke risk in the CC group than in the GC and GG groups ( GC + GG ). Multivariate unconditional logistic regression analysis showed that the CC genotype in ADRB1 (vs. the GC + GG genotype) was associated with an increased risk of stroke [odds ratio (OR) = 1.184, P <0.05] in hypertensive patients. No association was observed between CYP2D6 ∗ 10 , CYP2C9 ∗ 3 , AGTR1 ( 1166A > C ), ACE ( I / D ), CYP3A5 ∗ 3 , and NPPA ( 2238T > C ) polymorphisms and stroke. Conclusions . ADRB1 ( 1165G > C ) gene polymorphism is associated with the risk of stroke in Chinese hypertensive patients. The CC genotype is correlated with a higher risk of stroke than the GC + GG genotype.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) conducted an observational in Hypertension. ADRB1 (1165G>C) CC genotype vs. GC + GG genotype was evaluated on Stroke (OR 1.184, p=<0.05). The CC genotype of the ADRB1 (1165G>C) polymorphism was associated with an increased risk of stroke compared to the GC + GG genotype in Chinese hypertensive patients (OR 1.184, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: